Gelastatin A

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category Enzyme inhibitors
Catalog number BBF-01482
CAS
Molecular Weight 248.27
Molecular Formula C14H16O4
Purity ≥98%

Online Inquiry

Description

It is produced by the strain of Westerdykella multispora F50733. It can inhibit the activity of leucinase A and the IC50 of leucinase A is 0.63 μmol/L.

Specification

Synonyms (all-E)-5-(2,4-Hexadienylidene)-5,6-dihydro-2-oxo-2H-pyran-3-propanoic acid
Storage RT.
IUPAC Name 3-[(5E)-5-[(2E,4E)-hexa-2,4-dienylidene]-2-oxopyran-3-yl]propanoic acid
Canonical SMILES CC=CC=CC=C1COC(=O)C(=C1)CCC(=O)O
InChI InChI=1S/C14H16O4/c1-2-3-4-5-6-11-9-12(7-8-13(15)16)14(17)18-10-11/h2-6,9H,7-8,10H2,1H3,(H,15,16)/b3-2+,5-4+,11-6+
InChI Key ACFXHMLFZGREFW-JCESNKCLSA-N

Properties

Appearance White Powder

Reference Reading

1. Gelastatins and their hydroxamates as dual functional inhibitors for TNF-alpha converting enzyme and matrix metalloproteinases: synthesis, biological evaluation, and mechanism studies
Song-Kyu Park, Sang Bae Han, Kiho Lee, Ho Jae Lee, Yung Hee Kho, Hyokon Chun, Yongseok Choi, Jae Young Yang, Yeo Dae Yoon, Chang-Woo Lee, Hwan Mook Kim, Hyun-Moo Choi, Hyun Seop Tae, Hee-Yoon Lee, Ky-Youb Nam, Gyoonhee Han Biochem Biophys Res Commun. 2006 Mar 10;341(2):627-34. doi: 10.1016/j.bbrc.2005.12.219. Epub 2006 Jan 17.
The hydroxamic acid analogues (2) of the natural product gelastatins (1) were prepared by 1 step conversion reaction. The synthetic analogues (2) showed potent enzymatic inhibitory activities against MMP-2, MMP-9, and TACE IC50's of 6, 23, and 28 nM, respectively. In addition, 2 were able to inhibit TNF-alpha production effectively in mice as well as in a macrophage cell line, RAW 264.7. The protective effect of 2 also was examined on LPS-induced acute septic shock model. The mechanism of TNF-alpha inhibition was examined by RT-PCR and Western blot analyses. The relation of TACE and alpha-secretase was examined using cellular alpha-secretase assays on IMR-32 and SH-SY5Y cell lines. The docking mode of 2 with the catalytic domain of TACE was illustrated to analyze the binding mode for the further analogue design.
2. Synthesis of arylidene-substituted gelastatin analogues and their screening for MMP-2 inhibitory activity
Eun Jin Kim, Soo Y Ko Bioorg Med Chem. 2005 Jun 2;13(12):4103-12. doi: 10.1016/j.bmc.2005.03.037. Epub 2005 Apr 25.
A series of arylidene-substituted gelastatin analogues were synthesized in a divergent manner. Each analogue was obtained as a mixture of isomers. Calculation methods were devised to deduce the MMP-2 inhibitory activity of each isomer from the activity of an isomeric mixture and its composition. This protocol is suitable for rapidly generating a variety of arylidene-substituted gelastatin analogues and screening them for highly active inhibitors.

Recommended Products

BBF-03211 AT-265 Inquiry
BBF-05817 Astaxanthin Inquiry
BBF-00968 Homoalanosine Inquiry
BBF-03819 Spinosyn A Inquiry
BBF-03516 (±)-Naringenin Inquiry
BBF-02594 Pyrrolnitrin Inquiry

Bio Calculators

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Recently viewed products

Online Inquiry

Verification code

Copyright © 2025 BOC Sciences. All rights reserved.

cartIcon
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x